tiprankstipranks
Trending News
More News >
NEXUS AG (DE:NXU)
:NXU

NEXUS AG (NXU) AI Stock Analysis

Compare
11 Followers

Top Page

DE

NEXUS AG

(LSE:NXU)

Rating:72Outperform
Price Target:
NEXUS AG has a robust financial performance with strong revenue and cash flow metrics, supporting its operational strength. However, the absence of EBIT and relatively high valuation with a low dividend yield restrain its attractiveness. Technical indicators show stable momentum, but recent corporate events, such as significant managerial share sales and reduction in voting rights, pose risks to investor confidence and governance structure. These factors collectively result in a moderate overall stock score.

NEXUS AG (NXU) vs. iShares MSCI Germany ETF (EWG)

NEXUS AG Business Overview & Revenue Model

Company DescriptionNexus AG develops and sells software and hardware solutions, and provides IT services, primarily for customers in the health care system worldwide. It operates in two divisions, Healthcare Software and Healthcare Services. The company offers information systems, such as NEXUS/HIS and KIS for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/REHAB for rehabilitation facilities; ITR, a software for rehabilitation, clinics, and hotels with medical care; NEXUS/ARCHIVE and PEGASOS, an archiving and process management system; NEXUS/QM for quality management; NEXUS/INTEGRATION SERVER, an interface management; NEXUS/CLOUD IT, outsourcing solution; NEXUS/EPS, a software solution to supplement SAP personnel management, as well as process and HR consulting in the SAP environment; ifa systems, an ophthalmology software solution; Sophrona solutions, ophthalmology patients and referral program; and NEXUS/DIS, interdisciplinary diagnostic information system. Its information systems also comprise NEXUS/SWISSLAB, a laboratory information system; NEXUS/LAURIS for order communication in diagnostics; NEXUS/PATHOLOGY and NEXUS/CYTOLOGY for pathology and cytology institutes; dc-Pathos and dc-LabMan for pathology and cytology devices; NEXUS/RADIOLOGY, an information and image system for radiology wards and offices; NEXUs/CHILI, for PACS and teleradiology solutions; NEXUS/ASTRAIA for obstetrics and gynecology; NEXUS/SPECIAL DIAGNOSTICS and Clinic WinData for medical specialist diagnostics and device integration; NEXUS/HOME for senior citizen and nursing homes; NEXUS/OUTPATIENT CARE and Asebis, a homecare solution; NEXUS/PAT, an administration system for hospitals; and osoTEC for billing personal and other services. In addition, the company offers SINAPSI, highsystemNET, CREATIV OM, SEXTANT, Emed, NEXUS/EPD, NEXUS/AEMP, NEXUS/SPM, EuroSDS, RVS Software, NEXUS/VITA and TESIS VITA, and NEXUS/ESKULAP. NEXUS AG is headquartered in Donaueschingen, Germany.
How the Company Makes MoneyNEXUS AG generates revenue primarily through the sale and implementation of its proprietary software solutions tailored for the healthcare sector. The company offers a comprehensive suite of products, including electronic health records (EHR), hospital information systems (HIS), and specialized diagnostic software. Revenue streams include software licensing fees, which are typically charged on a subscription basis, and implementation services for deploying and customizing software solutions to meet the specific needs of healthcare providers. Additionally, NEXUS AG earns income from providing ongoing support, maintenance, and training services, ensuring that clients can effectively utilize their software systems. The company's financial performance is bolstered by strategic partnerships with healthcare institutions and technology providers, which help expand its market reach and enhance its product offerings.

NEXUS AG Financial Statement Overview

Summary
NEXUS AG exhibits strong financial performance with consistent revenue growth and solid cash flow generation. While the absence of EBIT in the latest report is a drawback, other profitability margins remain healthy. The balance sheet is characterized by low leverage and strong equity, ensuring financial stability. Robust cash flow metrics further underscore the company's operational efficiency and potential for sustained growth.
Income Statement
85
Very Positive
NEXUS AG has demonstrated consistent revenue growth with a solid revenue growth rate of 8.29% in the latest year. Gross profit margin is strong at 85.33%, though the lack of EBIT in the latest reporting year is a concern. EBITDA margin is healthy at 23.49%, indicating good operational efficiency. Net profit margin improved to 11.78%, showcasing enhanced profitability.
Balance Sheet
78
Positive
The company's balance sheet is stable with a low debt-to-equity ratio of 0.07, indicating low financial leverage. Return on Equity is decent at 11.03%, reflecting reasonable profitability relative to equity. The equity ratio stands at 63.82%, showcasing solid financial stability and a strong equity base.
Cash Flow
82
Very Positive
NEXUS AG shows a robust free cash flow growth rate of 96.38%, indicating strong cash generation capabilities. The operating cash flow to net income ratio is 1.67, suggesting efficient conversion of income to cash. With a free cash flow to net income ratio of 1.34, the company effectively turns profits into cash, supporting sustainable operations.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
261.46M241.46M209.13M188.18M162.94M
Gross Profit
223.09M65.97M176.46M159.09M141.60M
EBIT
38.42M24.77M28.49M24.27M17.21M
EBITDA
61.43M53.43M44.81M40.77M36.69M
Net Income Common Stockholders
30.82M24.03M19.35M17.15M14.92M
Balance SheetCash, Cash Equivalents and Short-Term Investments
117.23M99.00M110.95M26.30M28.63M
Total Assets
437.73M411.72M344.20M247.34M223.16M
Total Debt
20.91M20.25M18.67M16.63M13.15M
Net Debt
1.88M2.81M-1.35M-9.54M-13.29M
Total Liabilities
154.77M153.13M105.25M104.94M99.58M
Stockholders Equity
279.24M255.09M235.03M138.79M120.20M
Cash FlowFree Cash Flow
41.15M20.95M28.30M25.82M25.60M
Operating Cash Flow
51.54M30.41M33.88M31.39M30.95M
Investing Cash Flow
-30.32M-17.02M-98.55M-21.25M-22.00M
Financing Cash Flow
-19.63M-16.72M57.97M-11.08M-16.14M

NEXUS AG Technical Analysis

Technical Analysis Sentiment
Positive
Last Price72.60
Price Trends
50DMA
70.55
Positive
100DMA
69.64
Positive
200DMA
64.64
Positive
Market Momentum
MACD
0.55
Negative
RSI
58.86
Neutral
STOCH
58.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:NXU, the sentiment is Positive. The current price of 72.6 is above the 20-day moving average (MA) of 71.60, above the 50-day MA of 70.55, and above the 200-day MA of 64.64, indicating a bullish trend. The MACD of 0.55 indicates Negative momentum. The RSI at 58.86 is Neutral, neither overbought nor oversold. The STOCH value of 58.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:NXU.

NEXUS AG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
DENXU
72
Outperform
€1.25B38.5511.87%0.32%7.65%30.34%
64
Neutral
$12.87B9.817.76%16985.65%12.28%-7.83%
€1.16B33.135.26%6.17%
€45.86M10.8324.14%3.71%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:NXU
NEXUS AG
72.60
13.79
23.44%
GB:0MSD
CompuGroup Medical
22.10
-3.20
-12.65%
GB:0HI7
MeVis Medical Solutions
25.60
-5.60
-17.95%

NEXUS AG Corporate Events

Stock Buyback
NEXUS AG Updates on Share Buy-Back Program Progress
Neutral
Jun 2, 2025

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between May 26 and May 30, 2025, as part of their ongoing 2023 buy-back initiative. The total volume of shares repurchased so far amounts to 63,432, with transactions conducted exclusively on the Frankfurt Stock Exchange (Xetra) through a commissioned credit institution.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR70.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

Stock Buyback
NEXUS AG Reports on Share Buy-Back Program Progress
Neutral
May 26, 2025

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between May 19 and May 23, 2025. The program, which began on July 24, 2023, has so far resulted in the repurchase of 63,432 shares. These transactions are conducted through the Frankfurt Stock Exchange (Xetra) by a commissioned credit institution.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR70.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

Stock Buyback
NEXUS AG’s Share Buy-Back Program Update
Neutral
May 19, 2025

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between May 12 and May 16, 2025, as part of their ongoing initiative that began on July 24, 2023. The total volume of shares bought back under this program amounts to 63,432 shares, with purchases conducted through the Frankfurt Stock Exchange’s electronic platform, Xetra.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR70.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

Regulatory Filings and Compliance
Nexus AG Announces Change in Voting Rights
Neutral
May 13, 2025

Nexus AG announced a change in voting rights, with Brown Capital Management, LLC, a Baltimore-based entity, no longer holding any voting rights in the company. This change, effective from April 15, 2025, reflects a reduction from a previous 10.02% voting rights ownership to 0%, potentially impacting the company’s shareholder dynamics and market perception.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR70.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

Business Operations and StrategyRegulatory Filings and Compliance
Nexus AG Announces Significant Change in Voting Rights
Neutral
May 12, 2025

Nexus AG has announced a change in voting rights, with a significant reduction from 10.84% to 0.06%. This change involves the acquisition and disposal of shares and instruments, with Paul J. Glazer and Glazer Capital, LLC being key figures in the transaction. The announcement reflects a strategic shift in ownership structure, potentially impacting the company’s governance and stakeholder dynamics.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR70.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
NEXUS AG Reports Update on Share Buy-Back Program
Neutral
May 12, 2025

NEXUS AG announced that no shares were bought back between May 5 and May 9, 2025, as part of its ongoing share buy-back program, which started in July 2023. The total volume of shares repurchased under this program is 63,432, with transactions conducted exclusively on the Frankfurt Stock Exchange’s electronic trading platform, Xetra. This buy-back initiative reflects the company’s strategic approach to managing its capital structure and potentially enhancing shareholder value.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR70.0000 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

Business Operations and StrategyRegulatory Filings and Compliance
Nexus AG Announces Change in Voting Rights Structure
Neutral
May 5, 2025

Nexus AG has announced a significant change in its voting rights structure, with the total voting rights now reduced to 0% from a previous 5.96%. This change is due to the acquisition or disposal of shares with voting rights, as indicated by the notification obligation involving Gerald Glasauer and the Glasauer Investment Trust. This development may impact the company’s governance and influence within its shareholder structure, potentially affecting its strategic decisions and market positioning.

Stock BuybackBusiness Operations and Strategy
NEXUS AG Updates on Share Buy-Back Program
Neutral
May 5, 2025

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between April 28 and May 2, 2025. The program, initiated on July 24, 2023, has seen a total of 63,432 shares repurchased so far. These transactions are conducted via the Frankfurt Stock Exchange’s electronic platform, Xetra, through a commissioned credit institution. The announcement highlights the ongoing execution of the company’s capital market strategies.

Delistings and Listing ChangesShareholder Meetings
Nexus AG Faces Squeeze-Out Demand from Major Shareholder
Neutral
Apr 28, 2025

Nexus AG has received a squeeze-out demand from Project Neptune Bidco GmbH, a holding company managed by TA Associates Management, L.P. Project Neptune Bidco GmbH, which holds approximately 95.16% of Nexus AG’s share capital, is seeking to acquire the remaining shares from minority shareholders in exchange for cash compensation. The specifics of the cash compensation will be announced later, and a general meeting will be convened to finalize the transfer of shares.

Stock Buyback
NEXUS AG Updates on Share Buy-Back Program
Neutral
Apr 28, 2025

NEXUS AG announced that no shares were bought back between April 22 and April 25, 2025, as part of its ongoing share buy-back program initiated in July 2023. The total number of shares repurchased under this program remains at 63,432, with purchases conducted through the Frankfurt Stock Exchange’s Xetra platform, potentially impacting shareholder value and market perception.

Business Operations and StrategyRegulatory Filings and Compliance
Nexus AG Announces Major Change in Voting Rights
Neutral
Apr 23, 2025

Nexus AG, a company based in Donaueschingen, Germany, has announced a significant change in its voting rights structure. Luxunion S.A., a legal entity based in Luxembourg, has disposed of its shares with voting rights in Nexus AG, resulting in a reduction of voting rights from 10.06% to 0%. This change could impact Nexus AG’s shareholder dynamics and influence within the company, potentially affecting its strategic decisions and market positioning.

Regulatory Filings and Compliance
Nexus AG Announces Change in Voting Rights Structure
Neutral
Apr 22, 2025

Nexus AG, based in Donaueschingen, Germany, has announced a significant change in its voting rights structure. Raphael Kain, a natural person, has disposed of his shares with voting rights, resulting in a reduction of voting rights from 5.10% to 0.00%. This change could impact the company’s governance and influence future shareholder decisions.

Business Operations and StrategyRegulatory Filings and Compliance
Nexus AG Announces Major Change in Voting Rights
Neutral
Apr 22, 2025

Nexus AG has announced a significant change in its voting rights structure, with Morgan Stanley reducing its voting rights from 7.72% to 0.41%. This change reflects a substantial disposal of shares, potentially impacting the company’s governance and shareholder dynamics. The announcement may influence Nexus AG’s market perception, as stakeholders assess the implications of this shift in ownership.

Stock Buyback
NEXUS AG Updates on Share Buy-Back Program
Neutral
Apr 22, 2025

NEXUS AG, a company involved in the healthcare IT sector, announced that no shares were bought back during the period from April 14 to April 17, 2025, as part of its share buy-back program initiated in July 2023. The total volume of shares repurchased under this program amounts to 63,432 shares, with transactions conducted through the Frankfurt Stock Exchange’s electronic platform, Xetra.

Regulatory Filings and Compliance
Nexus AG Discloses Managerial Share Sale
Neutral
Apr 17, 2025

Nexus AG announced a managerial transaction involving Prof. Dr. Felicia Rosenthal, a member of the administrative or supervisory body, who sold shares valued at 29,750.00 EUR at a price of 70.00 EUR per share. The transaction took place outside a trading venue on April 14, 2025. This announcement, made in accordance with article 19 MAR, highlights the transparency and regulatory compliance of Nexus AG in disclosing managerial transactions, which could impact stakeholder perceptions and the company’s market positioning.

Other
Nexus AG Manager’s Share Sale Announcement
Neutral
Apr 17, 2025

Nexus AG announced a manager’s transaction involving Rolf Wöhrle, a member of the administrative or supervisory body, who sold shares outside a trading venue. The transaction involved the sale of shares at a price of 70.00 EUR each, totaling 106,850.00 EUR, which may impact the company’s stock market activities and stakeholder interests.

Other
Nexus AG Discloses Manager’s Share Sale
Neutral
Apr 17, 2025

Nexus AG announced a manager’s transaction involving the sale of shares by Andreas Heilig, a person closely associated with Ralf Heilig, a member of the managing body. The transaction, which took place outside a trading venue, involved the sale of shares at a price of 70.00 EUR each, totaling 350,000.00 EUR. This announcement may have implications for stakeholders as it reflects internal financial activities and could influence market perceptions of the company’s stock.

Business Operations and Strategy
Nexus AG Announces Major Share Sale by Managing Body Member
Neutral
Apr 17, 2025

Nexus AG announced a significant transaction involving the sale of shares by Dr. Ingo Behrendt, a member of the managing body. The transaction, which took place outside a trading venue, involved a total volume of 7,147,910 EUR at a price of 70.00 EUR per share. This announcement may have implications for the company’s market perception and stakeholder confidence, as such transactions often signal strategic moves or changes in the company’s operational focus.

Other
Nexus AG Announces Major Managerial Share Sale
Negative
Apr 17, 2025

Nexus AG, a company listed on the regulated market in Frankfurt and other German exchanges, announced a significant managerial transaction. Ralf Heilig, a member of the managing body, sold shares valued at 9,404,500 EUR outside a trading venue on April 14, 2025. This transaction could have implications for the company’s stock performance and investor sentiment, as it reflects significant insider activity.

Regulatory Filings and Compliance
Nexus AG Announces Managerial Share Transaction
Neutral
Apr 17, 2025

Nexus AG announced a transaction involving the sale of shares by a person closely associated with a member of its managing body, Dr. Ingo Behrendt. The transaction, which took place outside a trading venue, involved the sale of shares at a price of 70.00 EUR, totaling 701,400.00 EUR. This announcement is part of the company’s compliance with article 19 of the Market Abuse Regulation (MAR), highlighting transparency in managerial transactions.

Regulatory Filings and Compliance
Nexus AG Announces Major Share Transaction by Managing Body Member
Neutral
Apr 17, 2025

Nexus AG, a company involved in the sale of shares, announced a significant transaction involving a member of its managing body. Edgar Kuner, a member of the managing body, sold shares worth 16,894,570 EUR at a price of 70.00 EUR per share. This transaction was conducted outside a trading venue on April 14, 2025. The announcement is part of the company’s compliance with article 19 MAR, which mandates the disclosure of transactions by individuals in managerial positions.

Other
Nexus AG Announces Manager’s Share Transaction
Neutral
Apr 17, 2025

Nexus AG announced a manager’s transaction involving the sale of shares by Leo Vincent Behrendt, a person closely associated with Dr. Ingo Behrendt, a member of the managing body. The transaction, which took place outside a trading venue, involved the sale of shares at a price of 70.00 EUR per share, amounting to a total volume of 689,640.00 EUR. This announcement may impact stakeholders’ perception of the company’s stock and its market activities.

Other
Nexus AG Announces Manager’s Share Transaction
Neutral
Apr 17, 2025

Nexus AG announced a manager’s transaction involving the sale of shares by a person closely associated with a member of its managing body. The transaction, which took place outside a trading venue, involved the sale of shares worth 350,000 EUR at a price of 70.00 EUR each. This announcement may have implications for stakeholders as it reflects internal managerial decisions and could influence market perceptions of the company’s stock.

Business Operations and StrategyRegulatory Filings and Compliance
Nexus AG Announces Change in Voting Rights Structure
Neutral
Apr 17, 2025

Nexus AG has announced a significant change in its voting rights structure, with UBS Group AG now holding a reduced percentage of voting rights in the company. The new total of voting rights held by UBS is 0.18%, a substantial decrease from the previous 10.56%. This change in ownership structure may impact Nexus AG’s strategic decisions and influence within the healthcare software market.

Regulatory Filings and Compliance
Nexus AG Announces Major Change in Voting Rights
Neutral
Apr 17, 2025

Nexus AG has announced a significant change in its voting rights structure, as JPMorgan Chase & Co. has adjusted its shareholding, reducing its voting rights from 3.80% to 0.04%. This shift indicates a substantial disposal of shares by JPMorgan, which may impact Nexus AG’s shareholder composition and influence within the company.

Business Operations and Strategy
Nexus AG Announces Major Shareholder Restructuring
Neutral
Apr 15, 2025

Nexus AG has announced a significant change in its shareholder structure, with TA Associates Cayman, LLC now holding 95.08% of the voting rights through Project Neptune Bidco GmbH. This acquisition of shares marks a substantial increase from a previous holding of 3.47%, indicating a major shift in control and potentially impacting the company’s strategic direction and stakeholder interests.

Regulatory Filings and Compliance
Nexus AG Announces Change in Voting Rights
Neutral
Apr 14, 2025

Nexus AG has announced a change in voting rights, with The Goldman Sachs Group, Inc. adjusting its holdings. The total voting rights now stand at 3.98%, with a slight shift in the distribution between shares and instruments. This adjustment reflects ongoing changes in shareholder positions, potentially impacting Nexus AG’s governance and stakeholder dynamics.

Stock Buyback
NEXUS AG Reports Update on Share Buy-Back Program
Neutral
Apr 14, 2025

NEXUS AG announced that no shares were repurchased between April 7 and April 11, 2025, as part of its ongoing share buy-back program initiated in July 2023. To date, a total of 63,432 shares have been repurchased through the Frankfurt Stock Exchange’s Xetra platform, managed by a commissioned credit institution.

Business Operations and StrategyRegulatory Filings and Compliance
Nexus AG Announces Reduction in Voting Rights by Norwegian Ministry
Negative
Apr 14, 2025

Nexus AG, based in Donaueschingen, Germany, has announced a significant change in its voting rights structure. The Ministry of Finance on behalf of the State of Norway has reduced its voting rights in Nexus AG from 3.48% to 0.37%. This reduction in voting rights could impact the company’s governance and influence from the Norwegian government, potentially affecting its strategic decisions and market position.

Business Operations and StrategyRegulatory Filings and Compliance
Nexus AG Announces Change in Voting Rights
Neutral
Apr 9, 2025

Nexus AG has announced a change in voting rights, with The Goldman Sachs Group, Inc. crossing a threshold of 3% in voting rights through its subsidiary Goldman Sachs International. This adjustment in voting rights could influence Nexus AG’s shareholder dynamics and potentially impact its strategic decisions, reflecting the interest of major financial entities in the company’s operations.

Business Operations and StrategyRegulatory Filings and Compliance
Nexus AG Announces Change in Voting Rights
Neutral
Apr 8, 2025

Nexus AG, based in Donaueschingen, Germany, has announced a change in voting rights. The announcement details that Paul J. Glazer, through Glazer Capital, LLC, has increased his total voting rights in Nexus AG to 10.84%, up from a previous 5.06%. This change is significant as it reflects a substantial increase in influence over the company’s decisions, potentially impacting its strategic direction and stakeholder interests.

Stock Buyback
NEXUS AG Updates on Share Buy-Back Program
Neutral
Apr 7, 2025

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between March 31, 2025, and April 4, 2025. The company has repurchased a total of 63,432 shares under the 2023 program, conducted through the Frankfurt Stock Exchange’s Xetra platform, with a credit institution commissioned for the task. This announcement provides transparency on the company’s share buy-back progress, which could influence investor perceptions and market positioning.

Business Operations and StrategyRegulatory Filings and Compliance
Nexus AG Announces Changes in Voting Rights
Neutral
Apr 4, 2025

Nexus AG has released a voting rights announcement following the acquisition or disposal of shares with voting rights by The Goldman Sachs Group, Inc. The notification indicates that the threshold was crossed on March 28, 2025, with the total voting rights now standing at 3.98%. This change in voting rights could impact Nexus AG’s shareholder dynamics and influence its strategic decisions.

Business Operations and StrategyRegulatory Filings and Compliance
Nexus AG Announces Change in Voting Rights
Neutral
Apr 3, 2025

Nexus AG has announced a change in voting rights, with The Goldman Sachs Group, Inc. crossing a threshold of 3% voting rights through its subsidiary, Goldman Sachs International. This adjustment in voting rights could influence Nexus AG’s shareholder dynamics and potentially impact its strategic decisions, reflecting the company’s ongoing engagement with international financial entities.

Regulatory Filings and Compliance
Nexus AG Announces Change in Voting Rights
Neutral
Apr 2, 2025

Nexus AG, based in Donaueschingen, Germany, has announced a change in voting rights involving The Goldman Sachs Group, Inc. The notification indicates a decrease in the percentage of voting rights attached to shares from 3.55% to 2.97%, while the percentage through instruments increased from 0.43% to 1.01%, maintaining a total of 3.98%. This adjustment in voting rights could impact Nexus AG’s shareholder dynamics and influence future corporate decisions.

Stock Buyback
NEXUS AG Updates on Share Buy-back Program
Neutral
Mar 31, 2025

NEXUS AG announced that no shares were repurchased between March 24 and March 28, 2025, as part of its ongoing share buy-back program initiated in July 2023. The total shares repurchased under this program amount to 63,432, with transactions conducted exclusively on the Frankfurt Stock Exchange’s electronic platform, Xetra, through a commissioned credit institution.

Stock Buyback
NEXUS AG Reports No Share Buybacks in Recent Period
Neutral
Mar 24, 2025

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between March 17 and March 21, 2025. The program, which began on July 24, 2023, has so far resulted in the repurchase of 63,432 shares, conducted through a credit institution on the Frankfurt Stock Exchange’s Xetra platform. This announcement may impact investor perceptions and the company’s stock market activities.

Other
Nexus AG Announces Change in Voting Rights
Neutral
Mar 20, 2025

Nexus AG announced a change in voting rights, with The Goldman Sachs Group, Inc. reducing its stake in the company. The new total voting rights held by Goldman Sachs now stand at 3.11%, down from the previous 3.65%. This adjustment reflects a decrease in the percentage of voting rights attached to shares, which could impact Nexus AG’s shareholder dynamics and influence in decision-making processes.

Stock Buyback
NEXUS AG Reports on Share Buy-Back Program Progress
Neutral
Mar 17, 2025

NEXUS AG, a company operating in the healthcare software industry, announced that no shares were bought back during the period from March 10 to March 14, 2025, as part of its ongoing share buy-back program initiated in July 2023. The total volume of shares repurchased under this program amounts to 63,432 shares, with transactions executed via the Frankfurt Stock Exchange’s electronic trading platform, Xetra. This announcement may impact the company’s financial strategies and shareholder value, as the buy-back program is a tool for managing capital and potentially enhancing stock value.

Other
Nexus AG Announces Change in Voting Rights
Neutral
Mar 14, 2025

Nexus AG has announced a change in voting rights, with The Goldman Sachs Group, Inc. now holding 3.65% of the voting rights, up from a previous 3.66%. This adjustment reflects a slight decrease in the total voting rights percentage, which could influence the company’s governance dynamics and stakeholder interests.

Regulatory Filings and Compliance
Nexus AG Announces Change in Voting Rights
Neutral
Mar 13, 2025

Nexus AG announced a change in voting rights, with The Goldman Sachs Group, Inc. adjusting its shareholding. The new total of voting rights held by Goldman Sachs is 3.66%, with a slight decrease in shares directly attached to voting rights and an increase in voting rights through instruments. This adjustment in shareholding may influence Nexus AG’s shareholder dynamics and could have implications for its governance and decision-making processes.

Regulatory Filings and Compliance
Nexus AG Announces Change in Voting Rights
Neutral
Mar 10, 2025

Nexus AG has announced a change in voting rights, with The Goldman Sachs Group, Inc. now holding 3.11% of voting rights attached to shares and 0.54% through instruments, totaling 3.66%. This adjustment in voting rights reflects an acquisition or disposal of shares, potentially impacting Nexus AG’s shareholder structure and market positioning.

Stock Buyback
NEXUS AG Updates on Share Buy-Back Program
Neutral
Mar 10, 2025

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between March 3 and March 7, 2025, as part of their ongoing initiative that began on July 24, 2023. The total volume of shares repurchased under this program amounts to 63,432, with transactions conducted exclusively on the Frankfurt Stock Exchange’s electronic platform, Xetra, through a commissioned credit institution.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.